Vesiculopustular dermatosis: an uncommon side-effect of liraglutide?
Liraglutide is a GLP-1 receptor agonist, a novel medication for type 2 diabetes. We describe a case of pustules in a patient recently started on liraglutide. Common side effects of liraglutide are gastrointestinal disorders. Skin and tissue reactions are less well-known side effects. Liraglutide could be the cause of skin eruptions in this patient, possibly by immunogenicity.
Department of Internal Medicine, Groene Hart Hospital, Bleulandweg 10, 2800 BB Gouda Netherlands. fbesemer@gmail.com
Femke
F
Besemer
Arjan J
AJ
Verschoor
Michaela
M
Diamant
Roel P L M
RP
Hoogma
D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis*; D016903:Drug Monitoring; D004884:Eructation / Q000209:etiology; D005334:Fever / Q000209:etiology; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069450:Liraglutide; D008297:Male; D008875:Middle Aged; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D013909:Thorax
D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1